Related Experiment Video
Updated: Jun 26, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
The role of the mitochondrial permeability transition pore in heart disease
Andrew P Halestrap1, Philippe Pasdois
1Department of Biochemistry and Bristol Heart Institute, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK. A.Halestrap@Bristol.ac.uk
Insights
Mitochondria
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Cell Death Mechanisms
Background:
- Mitochondria are crucial for heart energy production, regulating ATP synthesis via calcium signaling.
- Mitochondrial dysfunction, driven by calcium overload and oxidative stress, triggers myocyte death in heart failure and reperfusion injury.
- The mitochondrial permeability transition pore (mPTP) is implicated in this cell death pathway.
Purpose of the Study:
- To investigate the role of the mitochondrial permeability transition pore (mPTP) in cardiovascular disease.
- To explore the potential of targeting the mPTP as a therapeutic strategy for heart conditions.
Main Methods:
- Investigated the molecular components of the mPTP, including cyclophilin-D (CyP-D), adenine nucleotide translocase (ANT), and phosphate carrier (PiC).
- Utilized cyclosporin A (CsA) and its analogues to inhibit mPTP opening.
- Examined the effects of mPTP inhibition in animal models of reperfusion injury and congestive heart failure.
Main Results:
- Evidence implicates CyP-D, ANT, and PiC in the formation of the mPTP.
- Inhibition of mPTP opening using CsA or genetic CyP-D ablation demonstrated significant protective effects in animal models.
- Clinical trials indicate CsA improves recovery following angioplasty for coronary thrombosis.
Conclusions:
- The mPTP is a key mediator of cell death in cardiovascular diseases like heart failure and reperfusion injury.
- Targeting the mPTP, particularly CyP-D, represents a promising therapeutic avenue for human cardiovascular diseases.
- Early clinical data supports the efficacy of mPTP inhibition in improving patient outcomes.
Abstract:
Like Dr. Jeckyll and Mr. Hyde, mitochondria possess two distinct persona. Under normal physiological conditions they synthesise ATP to meet the energy needs of the beating heart. Here calcium acts as a signal to balance the rate of ATP production with ATP demand. However, when the heart is overloaded with calcium, especially when this is accompanied by oxidative stress, mitochondria embrace their darker side, and induce necrotic cell death of the myocytes. This happens acutely in reperfusion injury and chronically in congestive heart failure. Here calcium overload, adenine nucleotide depletion and oxidative stress combine forces to induce the opening of a non-specific pore in the mitochondrial membrane, known as the mitochondrial permeability transition pore (mPTP). The molecular nature of the mPTP remains controversial but current evidence implicates a matrix protein, cyclophilin-D (CyP-D) and two inner membrane proteins, the adenine nucleotide translocase (ANT) and the phosphate carrier (PiC). Inhibition of mPTP opening can be achieved with inhibitors of each component, but targeting CyP-D with cyclosporin A (CsA) and its non-immunosuppressive analogues is the best described. In animal models, inhibition of mPTP opening by either CsA or genetic ablation of CyP-D provides strong protection from both reperfusion injury and congestive heart failure. This confirms the mPTP as a promising drug target in human cardiovascular disease. Indeed, the first clinical trials have shown CsA treatment improves recovery after treatment of a coronary thrombosis with angioplasty.
Related Concept Videos
The Inner Mitochondrial Membrane
Mitochondrial Membranes
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Structure of Porins
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

